Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132455) titled 'A Clinical Study of Sequential Immunotherapy and Chemotherapy After Concurrent Chemoradiotherapy for Conversion Treatment in Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma' on Sept. 14.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Soochow University
Condition:
Locally advanced unresectable esophageal squamous cell carcinoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-10-01
Target Sample Size: Trial Group (Combined Immunotherapy group):45;
Countries of Recruitment:
China
To know more, vis...